NancyMostafaJosephMD
Pathology • San Francisco, CAMolecular Genetics, Anatomic Pathology, Clinical Pathology
Resident Physician, Pathology, UCSF School of Medicine
Are you Dr. Joseph?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave M580
UCSF
San Francisco, CA 94143Phone+1 415-353-7359
Summary
- Dr. Nancy Joseph, MD is a board certified pathologist in San Francisco, California. She is currently licensed to practice medicine in California and Illinois. She is affiliated with UCSF Medical Center and Kaiser Permanente San Francisco Medical Center.
Education & Training
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2010 - 2014
University of Michigan Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2012 - 2026
IL State Medical License 1985 - 2023- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Factors associated with grade progression in pancreatic neuroendocrine tumors.Stephanie J Wang, Wesley Kidder, Nancy M Joseph, Bryan Khuong Le, Sheila Lindsay
Endocrine-Related Cancer. 2025-03-01 - 2 citationsHigh-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience.Merryl Terry, Minh P Nguyen, Vivian Tang, Ekin Guney, Krishna L Bharani
Endocrine Pathology. 2024-12-01 - 1 citationsProgression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53.Nancy M Joseph, Sarah E Umetsu, Grace E Kim, Merryl Terry, Arie Perry
Endocrine Pathology. 2024-12-01
Press Mentions
For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted TreatmentsNovember 16th, 2016
